Evidence map›Paper›PMID 36814274›Full record

ArticleOrphanet journal of rare diseases2023

The patient clinical journey and socioeconomic impact of osteogenesis imperfecta: a systematic scoping review.

Maria Rapoport, Michael B Bober, Cathleen Raggio, Lena Lande Wekre, Frank Rauch, Ingunn Westerheim, Tracy Hart, Taco van Welzenis, Arun Mistry, James Clancy and 3 more

Open access · goldAbstract readScoping Review
In one paragraph

Article in Orphanet journal of rare diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
25.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 5 countries.

Maria RapoportWickenstones Ltd, Abingdon, Oxfordshire, UK. maria@wickenstones.com.ORCID 0000-0003-2666-0579
Michael B BoberAlfred I. duPont Hospital, Wilmington, Delaware, USA.
Cathleen RaggioHospital for Special Surgery, New York, USA.
Lena Lande WekreTRS National Resource Center for Rare Disorders, Sunnaas Rehabilitation Hospital, Bjørnemyr, Nesodden, Norway.
Frank RauchMcGill University, Montreal, Canada.
Ingunn WesterheimOsteogenesis Imperfecta Federation Europe, Heffen, Belgium.
Tracy HartOsteogenesis Imperfecta Foundation, Gaithersburg, MD, USA.
Taco van WelzenisOsteogenesis Imperfecta Federation Europe, Heffen, Belgium.
Arun MistryMereo Biopharma, London, UK.
James ClancyMereo Biopharma, London, UK.
Lucy BoothWickenstones Ltd, Abingdon, Oxfordshire, UK.
Samantha PrinceWickenstones Ltd, Abingdon, Oxfordshire, UK.
Oliver SemlerUniversity of Cologne, Cologne, Germany.
CTI BioPharma (United Kingdom) · GBAlfred I. duPont Hospital for Children · USHospital for Special Surgery · USMcGill University · CAOsteogenesis Imperfecta Foundation · USSunnaas sykehus · NOUniversity of Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOsteogenesis imperfecta (OI) is a rare heritable connective tissue disorder primarily characterised by skeletal deformity and fragility, and an array of secondary features. The purpose of this review was to capture and quantify the published evidence relating specifically to the clinical, humanistic, and economic impact of OI on individuals, their families, and wider society.

methodsA systematic scoping review of 11 databases (MEDLINE, MEDLINE in-progress, EMBASE, CENTRAL, PsycINFO, NHS EED, CEA Registry, PEDE, ScHARRHUd, Orphanet and Google Scholar), supplemented by hand searches of grey literature, was conducted to identify OI literature published 1st January 1995-18th December 2021. Searches were restricted to English language but without geographical limitations. The quality of included records was assessed using the AGREE II checklist and an adapted version of the JBI cross-sectional study checklist.

resultsOf the identified 7,850 records, 271 records of 245 unique studies met the inclusion criteria; overall, 168 included records examined clinical aspects of OI, 67 provided humanistic data, 6 reported on the economic impact of OI, and 30 provided data on mixed outcomes. Bone conditions, anthropometric measurements, oral conditions, diagnostic techniques, use of pharmacotherapy, and physical functioning of adults and children with OI were well described. However, few records included current care practice, diagnosis and monitoring, interactions with the healthcare system, or transition of care across life stages. Limited data on wider health concerns beyond bone health, how these concerns may impact health-related quality of life, in particular that of adult men and other family members, were identified. Few records described fatigue in children or adults. Markedly few records provided data on the socioeconomic impact of OI on patients and their caregivers, and associated costs to healthcare systems, and wider society. Most included records had qualitative limitations.

conclusionDespite the rarity of OI, the volume of recently published literature highlights the breadth of interest in the OI field from the research community. However, significant data gaps describing the experience of OI for individuals, their families, and wider society warrant further research to capture and quantify the full impact of OI.

Indexed as

Osteogenesis ImperfectaAdultChildCross-Sectional StudiesHumansMaleQuality of LifeSocioeconomic FactorsAdultCaregiverClinicalEconomicHealth-related quality of lifeOsteogenesis imperfectaPaediatric

Identifiers

PMID36814274
PMCPMC9945474
OpenAlexW4321487630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.